Biotechnology

New patent for the drug Esperion Theraps NEXLIZET – DrugPatentWatch

[ad_1]

Copyright © DrugPatentWatch. Originally published in New patent for the drug Esperion Theraps NEXLIZET

Annual Drug Patent Expiration for NEXLIZET
Annual Drug Patent Expiration for NEXLIZET

Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from a single supplier. There are seven patents protecting this drug.

NEXLIZET drug price trend.

This drug has forty-four patent family members in twenty-two countries.

The generic ingredient in NEXLIZET is bempedoic acid; ezetimibe. One registered supplier for this compound. Additional details are available on bempedoic acid; ezetimibe profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published in New patent for the drug Esperion Theraps NEXLIZET

[ad_2]

Source link

Related Articles

Back to top button